Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antiviral drug |
| gptkbp:ATCCode |
P01BF08
|
| gptkbp:CASNumber |
4085-31-8
|
| gptkbp:chemicalClass |
gptkb:4-aminoquinoline
|
| gptkbp:chemicalFormula |
C38H54Cl2N8O8P2
|
| gptkbp:combines |
gptkb:dihydroartemisinin
|
| gptkbp:developedBy |
gptkb:China
|
| gptkbp:discoveredBy |
1960s
|
| gptkbp:eliminationHalfLife |
20-30 days
|
| https://www.w3.org/2000/01/rdf-schema#label |
piperaquine phosphate
|
| gptkbp:is_on_WHO_Model_List_of_Essential_Medicines |
true
|
| gptkbp:IUPACName |
1,3-bis[1-(7-chloroquinolin-4-yl)-1,4-piperazinyl]propane phosphate
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:molecularWeight |
999.7 g/mol
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
QT prolongation
gastrointestinal disturbance |
| gptkbp:usedFor |
malaria
|
| gptkbp:bfsParent |
gptkb:piperaquine
|
| gptkbp:bfsLayer |
7
|